RevitaCAM

meloxicam

  • Email
  • Help

About

The marketing authorisation for RevitaCAM has been withdrawn at the request of the marketing authorisation holder.

Name Language First published Last updated
RevitaCAM : EPAR - Summary for the public BG = bălgarski 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public ES = español 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public CS = čeština 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public DA = dansk 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public DE = Deutsch 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public ET = eesti keel 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public EL = elliniká 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public EN = English 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public FR = français 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public IT = italiano 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public LV = latviešu valoda 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public LT = lietuvių kalba 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public HU = magyar 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public MT = Malti 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public NL = Nederlands 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public PL = polski 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public PT = português 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public RO = română 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public SK = slovenčina 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public SL = slovenščina 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public FI = suomi 2012-03-14 2016-05-30
RevitaCAM : EPAR - Summary for the public SV = svenska 2012-03-14 2016-05-30

This EPAR was last updated on 30/05/2016 .

Authorisation details

Product details

Product details for RevitaCAM
NameRevitaCAM
Agency product numberEMEA/V/C/002379
Active substance

meloxicam

International non-proprietary name (INN) or common name

meloxicam

Species Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codeQM01AC06
Generic

A generic medicine is a medicine which is similar to a medicine that has already been authorised (the 'reference medicine'). A generic medicine contains the same quantity of active substance(s) as the reference medicine. Generic and reference medicines are used at the same dose to treat the same disease, and they are equally safe and effective.

Publication details

Publication details for RevitaCAM
Marketing-authorisation holder

Zoetis Belgium SA

Revision5
Date of issue of marketing authorisation valid throughout the European Union23/02/2012

Contact address:

Zoetis Belgium SA
Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Product information

Product information

05/10/2015  RevitaCAM -EMEA/V/C/002379 -T/0006

Name Language First published Last updated
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - Product Information SV = svenska 2012-03-14 2016-05-30

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.


Name Language First published Last updated
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30
RevitaCAM : EPAR - All Authorised presentations SV = svenska 2012-03-14 2016-05-30

Pharmacotherapeutic group

Anti-inflammatory and antirheumatic products, non-steroids (oxicams)

Therapeutic indication

Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders in dogs.

Assessment History

Changes since initial authorisation of medicine

Name Language First published Last updated
RevitaCAM : EPAR - Procedural steps taken and scientific information after authorisation SV = svenska 2012-09-28 2016-05-30

Initial marketing-authorisation documents

Name Language First published Last updated
RevitaCAM : EPAR - Public assessment report SV = svenska 2012-03-14 2016-05-30
CVMP summary of positive opinion for RevitaCAM SV = svenska 2011-12-09 2016-05-30